Centene Corporation (CNC) Earnings

Centene Corporation

CNC · NYSE

Sep 2026upcoming

Next quarter

Consensus is $0.07 EPS for Sep 2026 across 5 estimates, ranging $0.01 to $0.10.

CNC Jun 2026

Reported Jul 28, 2026

Beat 182.02%

EPS estimate: $0.89
EPS actual: $2.51
Revenue estimate: —
Revenue actual: —
1-day move: -3.27%

Call highlights have not been generated for this quarter.

Symbol: CNC
Type: Stock
Sector: Health Care
Industry: Medical Specialities
Country: North America
Exchange: NYSE

Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Key Issues

Bullish view

Zacks identifies Centene as a strong value stock and includes it among GARP candidates with discounted PEG ratios and long-term growth potential. That framing suggests the valuation may already reflect substantial concerns.

Bearish view

Centene’s financial trend weakened sharply, with fiscal 2025 revenue of $174.6 billion accompanied by a $6.7 billion net loss, versus $3.3 billion of net income in fiscal 2024. The loss makes the value case dependent on a demonstrated earnings recovery that the supplied evidence does not document.

Analyst Consensus

See all

Hold

20 analysts

$68

Current

—

Low

$71

Average

—

High

Average target implies +4.20% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Natera, Inc.NTRA · NASDAQ-GS$274.81